Pharmacologic rationale, efficacy and safety of the fixed-dose co-formulation of indacaterol and glycopyrronium

por Pelaia, Girolamo, Maselli, Rosario, Gallelli, Luca
Publicado no Multidiscip Respir Med (2014)

Dupilumab: a novel treatment for asthma

por Vatrella, Alessandro, Fabozzi, Immacolata, Calabrese, Cecilia, Maselli, Rosario, Pelaia, Girolamo
Publicado em 2014

Update on Anticytokine Treatment for Asthma

por Gallelli, Luca, Busceti, Maria Teresa, Vatrella, Alessandro, Maselli, Rosario, Pelaia, Girolamo
Publicado em 2013

Biological targets for therapeutic interventions in COPD: clinical potential

por Pelaia, Girolamo, Vatrella, Alessandro, Gallelli, Luca, Renda, Teresa, Caputi, Mario, Maselli, Rosario, Marsico, Serafino A
Publicado em 2006

Cellular Mechanisms Underlying Eosinophilic and Neutrophilic Airway Inflammation in Asthma

por Pelaia, Girolamo, Vatrella, Alessandro, Busceti, Maria Teresa, Gallelli, Luca, Calabrese, Cecilia, Terracciano, Rosa, Maselli, Rosario
Publicado no Mediators Inflamm (2015)

Respiratory infections and asthma

por Pelaia, Girolamo, Vatrella, Alessandro, Gallelli, Luca, Renda, Teresa, Cazzola, Mario, Maselli, Rosario, Marsico, Serafino A.
Publicado no Respir Med (2006)

Pharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPD

por Pelaia, Girolamo, Vatrella, Alessandro, Busceti, Maria Teresa, Gallelli, Luca, Calabrese, Cecilia, Terracciano, Rosa, Lombardo, Nicola, Maselli, Rosario
Publicado no Ther Clin Risk Manag (2015)

Role of biologics in severe eosinophilic asthma – focus on reslizumab

por Pelaia, Girolamo, Vatrella, Alessandro, Busceti, Maria Teresa, Gallelli, Luca, Preianò, Mariaimmacolata, Lombardo, Nicola, Terracciano, Rosa, Maselli, Rosario
Publicado no Ther Clin Risk Manag (2016)

Application of Proteomics and Peptidomics to COPD

por Pelaia, Girolamo, Terracciano, Rosa, Vatrella, Alessandro, Gallelli, Luca, Busceti, Maria Teresa, Calabrese, Cecilia, Stellato, Cristiana, Savino, Rocco, Maselli, Rosario
Publicado em 2014

COPD: maximization of bronchodilation

por Nardini, Stefano, Camiciottoli, Gianna, Locicero, Salvatore, Maselli, Rosario, Pasqua, Franco, Passalacqua, Giovanni, Pela, Riccardo, Pesci, Alberto, Sebastiani, Alfredo, Vatrella, Alessandro
Publicado em 2014

Update on optimal use of omalizumab in management of asthma

por Pelaia, Girolamo, Gallelli, Luca, Renda, Teresa, Romeo, Pasquale, Busceti, Maria Teresa, Grembiale, Rosa Daniela, Maselli, Rosario, Marsico, Serafino Antonio, Vatrella, Alessandro
Publicado em 2011

Theophylline action on primary human bronchial epithelial cells under proinflammatory stimuli and steroidal drugs: a therapeutic rationale approach

por Gallelli, Luca, Falcone, Daniela, Cannataro, Roberto, Perri, Mariarita, Serra, Raffaele, Pelaia, Girolamo, Maselli, Rosario, Savino, Rocco, Spaziano, Giuseppe, D’Agostino, Bruno
Publicado no Drug Des Devel Ther (2017)

Effects of simvastatin on cell viability and proinflammatory pathways in lung adenocarcinoma cells exposed to hydrogen peroxide

por Gallelli, Luca, Falcone, Daniela, Scaramuzzino, Monica, Pelaia, Girolamo, D’Agostino, Bruno, Mesuraca, Maria, Terracciano, Rosa, Spaziano, Giuseppe, Maselli, Rosario, Navarra, Michele, Savino, Rocco
Publicado no BMC Pharmacol Toxicol (2014)